The recent pace of drug development in America is nothing short of breathtaking. Within the last few years, drug companies have delivered effective therapies for COVID-19, cancer, Alzheimer's, diabetes, and obesity. By Sally C. Pipese Between 2010 and 2019, the Food and Drug Administration approved an average of 38 new drugs per year - 60% […]
This post COMMENTARY: Progressive fixation on drug pricing will impede progress appeared first on The Orlando Advocate.
